Gender- and age-specific rates of heart failure and other adverse cardiovascular outcomes in systemic sclerosis

Author:

Sun Guoli1,Yafasova Adelina1ORCID,Andersson Charlotte23ORCID,McMurray John J V4,Jhund Pardeep S4,Docherty Kieran F4,Faurschou Mikkel5,Nielsen Christoffer T5,Schou Morten2ORCID,Gislason Gunnar H26,Torp-Pedersen Christian78,Fosbøl Emil L1,Køber Lars1ORCID,Butt Jawad H1ORCID

Affiliation:

1. Department of Cardiology, Rigshospitalet, Copenhagen University Hospital , Copenhagen

2. Department of Cardiology, Herlev-Gentofte University Hospital , Hellerup, Denmark

3. Department of Medicine, Section of Cardiovascular Medicine, Boston Medical Center, Boston University , Boston, MA, USA

4. BHF Cardiovascular Research Centre, University of Glasgow , Glasgow, UK

5. Department of Rheumatology, Rigshospitalet, Copenhagen University Hospital

6. Danish Heart Foundation, Section of Cardiovascular Research , Copenhagen

7. Department of Cardiology, Nordsjællands Hospital , Hillerød

8. Department of Public Health, University of Copenhagen , Copenhagen, Denmark

Abstract

Abstract Objective To investigate the long-term rates of heart failure (HF) and other adverse cardiovascular outcomes, including arrhythmias, myocardial infarction, ischaemic stroke, venous thromboembolism, pulmonary hypertension and pericarditis, in SSc patients according to gender and age. Methods Using Danish nationwide registries, SSc patients (diagnosed from 1996 to 2018) were matched with four controls from the background population by gender, age and comorbidities. Cox regression was used to compare the rates of cardiovascular outcomes between SSc patients and controls and the rate of mortality between SSc patients developing HF and HF patients without SSc, according to gender and age (above/below median). Results In total, 1569 SSc patients were matched with 6276 non-SSc controls (median age 55 years, 80.4% women, median follow-up 7.3 years). SSc had a higher rate of HF in both women [HR 2.99 (95% CI 2.18, 4.09)] and men [HR 3.01 (1.83, 4.95)] (Pinteraction = 0.88), with similar trends for other cardiovascular outcomes. SSc had a higher rate of HF in patients <55 years of age [HR 4.14 (95% CI 2.54, 6.74)] and ≥55 years [HR 2.74 (1.98, 3.78)] (Pinteraction = 0.22), with similar trends for other cardiovascular outcomes. SSc patients with new-onset HF had a higher rate of mortality than HF patients without a history of SSc, irrespective of gender (Pinteraction = 0.53) and age (Pinteraction = 0.43). Conclusions SSc was associated with higher rates of HF and other cardiovascular outcomes than matched controls, irrespective of gender and age. Among patients with new-onset HF, a history of SSc was associated with higher mortality.

Funder

AstraZeneca

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3